Antithrombotic and angiotensin-converting enzyme inhibitory properties of peptides released from bovine casein by Lactobacillus casei Shirota

International Dairy Journal

Volumn 26, Issue 2, 2012, Pages 147-154

  Rojas Ronquillo, Rebeca ^a   Cruz Guerrero, Alma ^a   Flores Nájera, Angélica ^a   Rodríguez Serrano, Gabriela ^a   Gómez Ruiz, Lorena ^a   Reyes Grajeda, Juan Pablo ^b   Jiménez Guzmán, Judith ^a   García Garibay, Mariano ^a,c  

^a DEPARTAMENTO DE QUÍMICA   (Mexico)

^b INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

^c Metroipolitan Autonomous University Lerma   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ACE-INHIBITORY; ACTIVE PEPTIDES; ANGIOTENSIN-CONVERTING ENZYME; ANTITHROMBOTIC; DIGESTIVE ENZYMES; INHIBITION EFFICIENCY; INHIBITORY ACTIVITY; LACTOBACILLUS CASEI; STREPTOCOCCUS THERMOPHILUS; THROMBIN INHIBITION;

FERMENTATION; MAMMALS; PEPTIDES; PROTEOLYSIS;

ENZYME INHIBITION;

BOVINAE; LACTOBACILLUS CASEI; STREPTOCOCCUS THERMOPHILUS;

EID: 84863860097     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2012.05.002     Document Type: Article

References (47)

1. Chen G.W., Tsai J.S., Pan B.S. Purification of angiotensin I-converting enzyme inhibitory peptides and antihypertensive effect of milk produced by protease-facilitated lactic fermentation. International Dairy Journal 2007, 17:641-647.
2. Coste M., Rochet V., Leonil J., Molle D., Bouhallab S., Tome D. Identification of C-terminal peptides from bovine β-casein that enhance proliferation of rat lymphocytes. Immunology Letters 1992, 33:41-46.
3. Erdmann K., Cheung B.W.Y., Schröder H. The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease. Journal of Nutritional Biochemistry 2008, 19:643-654.
4. Fiat A.M., Jollés P. Caseins of various origins and biologically active casein peptides and oligosaccharides: structural and physiological aspects. Molecular and Cellular Biochemistry 1989, 87:5-30.
5. FitzGerald R.J., Murray B.A. Bioactive peptides and lactic fermentations. International Journal of Dairy Technology 2006, 59:118-125.
6. Fuglsang A., Nilsson D., Nyborg N.C.B. Cardiovascular effects of fermented milk containing angiotensin-converting enzyme inhibitors evaluated in permanently catheterized, spontaneously hypertensive rats. Applied and Environmental Microbiology 2002, 68:3566-3569.
7. Gasteiger E., Hoogland C., Gattiker A., Duvaud S., Wilkins M.R., Appel R.D., et al. Protein identification and analysis tools on the ExPASy Server. The proteomics protocols handbook 2005, Humana Press, New York City, NY, USA, Retrieved from. http://www.expasy.org, J.M. Walker (Ed.).
8. González-González C.R., Tuohy K.M., Jauregi P. Production of angiotensin-I-converting enzyme (ACE) inhibitory activity in milk fermented with probiotic strains: effects of calcium, pH and peptides on the ACE-inhibitory activity. International Dairy Journal 2011, 21:615-622.
9. González-Olivares L.G., Jiménez-Gúzman J., Cruz-Guerrero A., Rodríguez-Serrano G., Gómez-Ruiz L., García-Garibay M. Liberación de péptidos bioactivos por bacterias lácticas en leches fermentadas comerciales. Revista Mexicana de Ingeniería Química 2011, 10:179-188.
10. Gresele P., Agnelli G. Novel approaches to the treatment of thrombosis. Trends in Pharmacology Science 2002, 23:25-32.
11. Hayakari M., Kondo Y., Izumi H. A rapid and simple spectrophotometric assay of angiotensin-converting enzyme. Analytical Biochemistry 1978, 84:361-369.
12. Hayes M., Stanton C., FitzGerald G.F., Ross R.P. Putting microbes to work: dairy fermentation, cell factories and bioactive peptides. Part II: bioactive peptide functions. Biotechnology Journal 2007, 2:435-449.
13. Hayes M., Stanton C., Slattery H., O'Sullivan O., Hill C., FitzGerald G.F., et al. Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors. Applied and Environmental Microbiology 2007, 73:4658-4667.
14. Hernández-Ledesma B., Amigo L., Ramos M., Recio I. Angiotensin converting enzyme inhibitory activity in commercial fermented products. Formation of peptides under simulated gastrointestinal digestion. Journal of Agricultural and Food Chemistry 2004, 52:1504-1510.
15. Hernández-Ledesma B., Miralles B., Amigo L., Ramos M., Recio I. Identification of antioxidant and ACE-inhibitory peptides in fermented milk. Journal of the Science of Food and Agriculture 2005, 85:1041-1048.
16. Hirsh J., O'Donnell M., Weitz J.I. New anticoagulants. Blood 2005, 105:453-463.
17. Hong F., Ming L., Yi S., Zhanxia L., Yongquan W., Chi L. The antihypertensive effect of peptides: a novel alternative to drugs?. Peptides 2008, 29:1062-1071.
18. Jollès P., Levy-Toledano S., Fiat A.M., Soria C., Gillessen D., Thomaidis A., et al. Analogy between fibrinogen and casein. Effect of an undecapeptide isolated from kappa-casein on platelet function. European Journal of Biochemistry 1986, 158:379-382.
19. Kawase M., Hashimoto H., Hosoda M., Morita H., Hosono A. Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids and blood pressure. Journal of Dairy Science 2000, 83:255-263.
20. Khalid N.M., Marth A.H. Proteolytic activity by strains of Lactobacillus plantarum and Lactobacillus casei. Journal of Dairy Science 2010, 73:3068-3076.
21. Kojic M., Fira D., Banina A., Topisirovic L. Characterization of the cell wall-bound proteinase of Lactobacillus casei HN14. Applied and Environmental Microbiology 1991, 57:1753-1757.
22. Korhonen H., Pihlanto A. Bioactive peptides: production and functionality. International Dairy Journal 2006, 16:945-960.
23. Lozo J., Strahinic I., Dalgalarrondo M., Chobert J.M., Haertlé T., Topisirovic L. Comparative analysis of β-casein proteolysis by PrtP proteinase from Lactobacillus paracasei subsp. paracasei BGHN14, PrtP proteinase from Lactobacillus rhamnosus BGT10 and PrtH proteinase from Lactobacillus helveticus BGRA43. International Dairy Journal 2011, 21:863-868.
24. Matar C., LeBlanc J.G., Martin L., Perdigón G. Biologically active peptides released in fermented milk: role and functions. Handbook of fermented functional foods 2003, 177-199. CRC Press LLC, Boca Raton, FL, USA. E.R. Farnworth (Ed.).
25. Meisel H. Multifunctional peptides encrypted in milk proteins. BioFactors 2004, 21:55-61.
26. Möller N.P., Scholz-Ahrens K.E., Roos N., Schrezenmeir J. Bioactive peptides and proteins from foods: Indication for health effects. European Journal of Nutrition 2008, 47:171-182.
27. Muguerza B., Ramos M., Sánchez E., Manso M.A., Miguel M., Aleixandre A., et al. Antihypertensive activity of milk fermented by Enterococcus faecalis strains isolated from raw milk. International Dairy Journal 2006, 16:61-69.
28. Muro-Urista C., álvarez-Fernández R., Riera-Rodriguez F., Arana-Cuenca A., Téllez-Jurado A. Review: production and functionality of active peptides from milk. Food Science and Technology International 2011, 17:293-317.
29. Nakamura Y., Yamamoto N., Sakai K., Takano T. Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. Journal of Dairy Science 1995, 78:1253-1257.
30. Nielsen M.S., Martinussen T., Flambard B., Sorensen K.I., Otte J. Peptide profiles and angiotensin-I-converting enzyme inhibitory activity of fermented milk products: effect of bacterial strain, fermentation pH, and storage time. International Dairy Journal 2009, 19:155-165.
31. Ohsawa K., Satsu H., Ohki K., Enjoh M., Takano T., Shimizu M. Producibility and digestibility of antihypertensive beta-casein tripeptides, Val-Pro-Pro and Ile-Pro-Pro, in the gastrointestinal tract: analyses using an in vitro model of mammalian gastrointestinal digestion. Journal of Agricultural and Food Chemistry 2008, 56:854-858.
32. Perdigón G., Alvarez S., Pesce de Ruiz Holgado A. Immunoadjuvant activity of oral Lactobacillus casei: influence of dose on the secretory immune response and protective capacity in intestinal infections. Journal of Dairy Research 1991, 58:485-496.
33. Quirós A., Contreras M.M., Ramos M., Amigo L., Recio I. Stability to gastrointestinal enzymes and structure-activity relationship of β-casein-peptides with antihypertensive properties. Peptides 2009, 30:1848-1853.
34. Raha S., Dosquet C., Abgrall J.F., Jollès P., Fiat A.M., Caen J.P. KRDS a tetrapeptide derived from lactotransferrin inhibits binding of monoclonal antibody against glycoprotein IIb-IIIa on ADP-stimulated platelets and megakaryocytes. Blood 1988, 72:172-178.
35. Robert M.C., Razaname A., Mutter M., Juillerat M.A. Identification of angiotensin-I-converting enzyme inhibitory peptides derived from sodium caseinate hydrolysates produced by Lactobacillus helveticus NCC 2765. Journal of Agricultural and Food Chemistry 2004, 52:6923-6931.
36. Rokka T., Syväoja E.L., Tuominen J., Korhonen H. Release of bioactive peptides by enzymatic proteolysis of Lactobacillus GG fermented UHT milk. Milchwissenschaft 1997, 52:675-678.
37. Rutherfurd K.J., Gill H.S. Peptides affecting coagulation. British Journal of Nutrition 2000, 84:S99-102.
38. Saito T. Antihypertensive peptides derived from bovine casein and whey proteins. Advances in experimental medicine and biology: Bioactive components of milk 2008, Vol. 606:295-317. Springer, New York, USA.
39. Sandre C., Gleizes A., Forestier F., Gorges-Kergot R., Chilmonczyk S., Leonil J., et al. A peptide derived from bovine β-casein modulates functional properties of bone marrow-derived macrophages from germ free and human flora-associated mice. Journal of Nutrition 2001, 131:2936-2942.
40. Savijoki K., Ingmer H., Varmanen P. Proteolytic systems of lactic acid bacteria. Applied Microbiology and Biotechnology 2006, 71:394-406.
41. Schägger H., von Jagow G. Tricine-sodium dodecyl sulfate-poliacrilamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Analytical Biochemistry 1987, 166:368-379.
42. Shah N.P. Functional cultures and health benefits. International Dairy Journal 2007, 17:1262-1277.
43. Silva S.V., Malcata F.X. Caseins as source of bioactive peptides. International Dairy Journal 2005, 15:1-15.
44. Vermeirssen V., Van Camp J., Verstraete W. Bioavailability of angiotensin I converting enzyme inhibitory peptides. British Journal of Nutrition 2004, 92:357-366.
45. Yamamoto N., Akino A., Takano T. Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. Journal of Dairy Science 1994, 77:917-922.
46. Yang W.G., Wang Z., Xu S.Y. A new method for determination of antithrombotic activity of egg white protein hydrolysate by microplate reader. Chinese Chemical Letters 2007, 18:449-451.
47. Zhang S.B., Wang Z., Xu S.Y. Antioxidant and antithrombotic activities of rapeseed peptides. Journal of the American Oil Chemists' Society 2008, 85:521-527.